Plaque stabilisation by systemic and local drug administration.
Spratt
J C
JC
Royal Infirmary of Edinburgh, Edinburgh, UK.
Camenzind
E
E
D000284:Administration, Oral; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D006328:Cardiac Catheterization / Q000379:methods; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D012307:Risk Factors; D015607:Stents
D000806:Angiotensin-Converting Enzyme Inhibitors; D005343:Fibrinolytic Agents; D000960:Hypolipidemic Agents